The importance of lipid modulation by MAGL inhibition was further underscored by a recent study showing that JZL184-mediated blockade of oleic acid-stimulated proliferation of glioblastoma cells occurs via modulation of triglyceride metabolism and not via changes in cannabinoid receptor signalling pathways [126]. The gene discussed is MGLL; the disease is glioblastoma.